RxDoctor Payments Data

Adnan Khan, MD

Interventional Pain Medicine · Georgetown, TXNPI 1083861249

Payments from drug & device makers

$6,740in general payments, 2019–2025

Across 124 payments — averaging $54.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GRT US Holding, Inc.$2K
  • Medtronic$2K
  • Boston Scientific$802
  • Vertiflex, Inc.$388
  • Globus Medical$343
  • Spinal Simplicity, LLC$226
  • plus $820 from 17 others

What the payments were for

  • Speaking & faculty fees$2,00030%
  • Travel & lodging$92714%
  • Food & beverage$3,70455%
  • Education$991%
  • Gifts$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,740 in reported general payments places this provider in the 45th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$229,662
Medicare patients
224
Services billed
4,896

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine20$7,438
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen99$1,615
Pregabalin104$1,530
Gabapentin134$1,453
Tramadol Hcl ErTramadol Hcl16$820
Tramadol Hcl106$518
Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol13$386
Duloxetine Hcl15$366
Cyclobenzaprine Hcl42$310
Oxycodone Hcl13$152
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$150
Tizanidine Hcl20$139
Memantine Hcl13$108
Hydromorphone Hcl11$45

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Georgetown

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →